CORRELATION OF CLINICAL RESPONSE WITH PATIENT-REPORTED OUTCOMES IN THE AMPLE (ABATACEPT VERSUS ADALIMUMAB COMPARISON IN BIOLOGIC-NAIVE RA PATIENTS WITH BACKGROUND METHOTREXATE) TRIAL: 2-YEAR RESULTS

被引：0
|
作者：
Fleischmann, R. [1 ]
Weinblatt, M. [2 ]
Schiff, M. [3 ]
Khanna, D. [4 ]
Maldonado, M. [5 ]
Nadkarni, A. [5 ]
Fay, J. [5 ]
Furst, D. [6 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Univ Colorado, Denver, CO 80202 USA
[4] Univ Michigan, Ann Arbor, MI 48109 USA
[5] Bristol Myers Squibb Co, Princeton, NJ USA
[6] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.2113
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0246
引用
收藏
页码：681 / 682
页数：2
相关论文
共 50 条
  • [41] Similar Improvements in Patient-Reported Outcomes Among Rheumatoid Arthritis Patients Treated with Two Different Doses of Methotrexate in Combination with Adalimumab: Results From the MUSICA Trial
    Gurjit S. Kaeley
    Daryl K. MacCarter
    Janak R. Goyal
    Shufang Liu
    Kun Chen
    Jennifer Griffith
    Hartmut Kupper
    Vishvas Garg
    Jasmina Kalabic
    [J]. Rheumatology and Therapy, 2018, 5 : 123 - 134
  • [42] Patient-Reported Outcomes from a Randomised, Open-Label, Parallel-Group Study Evaluating Ixekizumab versus Adalimumab in Patients with PsA Who Are Biologic DMARD Naive: 24-Week Results
    Van den Bosch, Filip
    Kristensen, Lars-Erik
    McGonagle, Dennis
    Rossini, Maurizio
    Liu-Leage, Soyi
    Sapin, Christophe
    Meszaros, Gabriella
    Merola, Joseph
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [43] Abatacept provides significant and sustained benefits in clinical and patient reported outcomes through 2 yrs in patients with rheumatoid arthritis (RA) and an inadequate response to methotrexate (MTX): The long-term extension (LTE) of the aim trial
    Kremer, J. M.
    Emery, P.
    Becker, J. P.
    Aranda, R.
    Teng, J.
    Li, T.
    Westhovens, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 327 - 327
  • [44] Effects of Disease-Worsening Following Withdrawal of Etanercept or Methotrexate on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis Results From the SEAM-RA Trial
    Curtis, Jeffrey R.
    Stolshek, Bradley
    Emery, Paul
    Haraoui, Boulos
    Karis, Elaine
    Kricorian, Greg
    Collier, David H.
    Yen, Priscilla K.
    Bykerk, Vivian P.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2023, 29 (01) : 16 - 22
  • [45] Correlation of 2-year SRS-22r and ODI patient-reported outcomes with 5-year patient-reported outcomes after complex spinal fusion: a 5-year single-institution study of 118 patients
    Adogwa, Owoicho
    Karikari, Isaac O.
    Elsamadicy, Aladine A.
    Sergesketter, Amanda R.
    Galan, Diego
    Bridwell, Keith H.
    [J]. JOURNAL OF NEUROSURGERY-SPINE, 2018, 29 (04) : 422 - 428
  • [46] Improvement in Patient-Reported Outcomes in Patients Aged 2-5 Years with Polyarticular-Course JIA Treated with Subcutaneous Abatacept: 2-Year Results from a Phase III International Study
    Brunner, Hermine
    Tzaribachev, Nikolay
    Louw, Ingrid
    Anton, Jordi
    Viola, Diego
    Lauwerys, Bernard
    Cuttica, Ruben J.
    Quartier, Pierre
    Gervais, Elisabeth
    Belot, Alexandre
    Minden, Kirsten
    Lutz, Thomas
    Cimaz, Rolando
    Ally, Mahmood M. T. M.
    van Zyl, Riana
    Penades, Inmaculada Calvo
    Zhuo, Joe
    Wong, Robert
    Nys, Marleen
    Elbez, Yedid
    Martini, Alberto
    Lovell, Daniel J.
    Ruperto, Nicolino
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [47] IMPACT OF ADALIMUMAB VERSUS NON-BIOLOGIC THERAPY ON CLINICAL AND PATIENT-REPORTED OUTCOMES IN PSORIATIC ARTHRITIS OVER 24 MONTHS - RESULTS OF THE COMPLETE-PsA CANADIAN OBSERVATIONAL STUDY
    Khraishi, M.
    Silverberg, S.
    Setty, Y.
    Laliberte, M. C.
    Bessette, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1312 - 1313
  • [48] Patient-Reported Outcomes of Upadacitinib versus Adalimumab Use in Patients with Moderately to Severely Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate: 26-Week Analysis of a Phase 3 Study
    Fleischmann, Roy
    Bergman, Martin
    Tundia, Namita
    Song, In-Ho
    Suboticki, Jessica
    Song, Yan
    Strand, Vibeke
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [49] Safety and patient-reported outcomes through 2 years of treatment with abatacept in rheumatoid arthritis patients receiving background disease-modifying antirheumatic drugs (DMARDS): The assure trial
    Weinblatt, M. E.
    Keystone, E.
    Combe, B.
    Birbara, C.
    [J]. JOURNAL OF RHEUMATOLOGY, 2007, 34 (07) : 1631 - 1631
  • [50] Improvement in Clinical Disease Activity and Patient-Reported Outcomes After 6 Months of Treatment with Abatacept, Stratified by Line of Therapy, in Patients with RA: Results from a Large, US, National Observational Study
    Harrold, Leslie
    Wittstock, Keith
    Kelly, Sheila
    Park, Sang Hee
    Han, Xue
    Shan, Ying
    Roberts-Toler, Carla
    Middaugh, Nicole
    Khaychuk, Vadim
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1671 - 1673
12345